The invention provides novel methods of administering anti-CD3 antibodies,e.g., via oral or mucosal delivery. The invention also provides methods oftreating, preventing, or delaying the onset of autoimmune disorders by oral ormucosal administration of anti~-CD3 antibodies. Finally, the inventionprovides compositions including anti-CD3 antibodies, suitable for oral ormucosal administration.